Cameron Trenor, MD
Co-Director, Cerebrovascular Disorders and Stroke Program
Director of Clinical Research - Vascular Anomalies Center
|Academic Title||Instructor in Pediatrics|
300 Longwood Ave, Karp 8
Boston, MA 02115
Dr. Trenor conducts basic science research on hemostasis and thrombosis in the laboratory of Drs. Bruce and Barbara Furie at Beth Israel Deaconess Medical Center. Currently funded by a K08 award from the NHLBI, this research currently focuses on platelet biology utilizing an in vivo model of laser-activated thrombosis.
Dr. Trenor also conducts clinical and translational research in vascular anomalies, stroke and thromboprophylaxis in pediatric patients. He is particularly interested in developing novel therapies for patients with vascular malformations and tumors. He currently is a co-PI for a phase 2 study of sirolimus in complex vascular anomalies and has additional trials in development for vascular anomalies. He is PI for a lymphatic anomalies registry and is developing a database of pediatric stroke patients. He is a co-investigator in the International Paediatric Stroke Study and co-director of the Cerebrovascular Disorders and Stroke Program.
About Cameron Trenor
Dr. Trenor received his MD from the University of Tennessee Memphis. His general pediatric residency was in the Boston Combined Residency Program at Boston Children's Hospital and Boston Medical Center. His pediatric hematology-oncology fellowship training was at Boston Children's Hospital and Dana-Farber Cancer Institute.
Fleming MD, Trenor CC 3rd, Su MA, Foernzler D, Beier DR, Dietrich WF, Andrews NC. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nature Genetics 1997; 16(4):383-6.
Trenor CC 3rd, Campagna DR, Sellers VM, Andrews NC, Fleming MD. The molecular defect in hypotransferrinemic mice. Blood 2000; 96(3):1113-8.
Trenor CC 3rd and Michelson AD. Thrombophilia and Pediatric Stroke. Circulation 2010; 121(16):1795-7.
Zitomersky N, Verhave M, Trenor CC 3rd. Thrombosis and Inflammatory Bowel Disease: Risk Management and Clinical Guidance. Inflammatory Bowel Diseases 2011; 17(1):458-70.
Trenor CC 3rd, Chung RC, Michelson AD, Neufeld EJ, Gordon CM, Laufer MR, Emans SJ. Hormonal Contraception and Thrombotic Risk: A Multidisciplinary Approach. Pediatrics 2011, 127(2):347-57.
Zwicker JI, Trenor CC3rd, Furie BC, Furie B. Tissue factor-bearing microparticles and thrombus formation. Arteriosclerosis, Thrombosis and Vascular Biology 2011; 31(4):728-33.
Trenor CC3rd. Sirolimus for Refractory Vascular Anomalies. Pediatric Blood and Cancer 2011 Dec 1;57(6):904-5.